One of the exciting and frustrating things about convergence, particularly in healthcare, is that it’s tough to predict how the hybrid technologies will find their way to market. The process of reaching that goal is filled with unexpected obstacles, twists and pivots.
{iframe}http://medcitynews.com/2015/06/eric-topol-convergence-digital-health-clinical-trials/{/iframe}